State IL
Clinical Trials in Illinois
Recruiting clinical trials with at least one study location in Illinois. Data updated daily from ClinicalTrials.gov.
Top Conditions in Illinois
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT04929028 Phase 2
Recruiting
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Condition
AIDS-Related Anal Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07116876 N/A
Recruiting
Matrion Decellularized Placental Membrane Versus Conventional Wound Management i...
Condition
Diabetic Foot Ulcer (DFU)
Enrollment
120 pts
Location
United States
Sponsor
LifeNet Health
NCT04064060 Phase 3
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Ot...
Condition
Myelodysplastic Syndromes (MDS)
Enrollment
665 pts
Location
United States, Australia, Belgium
Sponsor
Celgene
NCT06385886 N/A
Recruiting
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for S...
Condition
Sickle Cell Disease
Enrollment
500 pts
Location
United States
Sponsor
RTI International
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT07145229 Phase 2
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Condition
Acute Gouty Arthritis
Enrollment
380 pts
Location
United States, Australia, China
Sponsor
Atom Therapeutics Co., Ltd
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT06531473 N/A
Recruiting
Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP...
Condition
Urologic Diseases
Enrollment
300 pts
Location
United States
Sponsor
Northwestern University
NCT05504837 Phase 1
Recruiting
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Condition
Cystic Fibrosis
Enrollment
12 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarco...
Condition
Alveolar Soft Part Sarcoma
Enrollment
325 pts
Location
United States, China, Italy
Sponsor
Advenchen Laboratories, LLC
NCT06436742 Phase 1
Recruiting
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Par...
Condition
Congenital Myasthenic Syndrome
Enrollment
16 pts
Location
United States, Canada, France
Sponsor
argenx
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants Wit...
Condition
Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canada
Sponsor
Inmagene LLC
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT06071845 N/A
Recruiting
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of E...
Condition
Barrett Esophagus
Enrollment
400 pts
Location
United States
Sponsor
Mayo Clinic
NCT07216872 N/A
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation...
Condition
Alcohol Use Disorder
Enrollment
186 pts
Location
United States, Israel
Sponsor
Brainsway
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT03401762 N/A
Recruiting
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
Condition
Stroke
Enrollment
96 pts
Location
United States
Sponsor
Northwestern University
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT06499857 Phase 3
Recruiting
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrilla...
Condition
Overweight or Obesity
Enrollment
200 pts
Location
United States
Sponsor
University of Chicago
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT05357040 Phase 2
Recruiting
Antidepressant Effects of Nitrous Oxide
Condition
Major Depressive Disorder
Enrollment
172 pts
Location
United States, Australia
Sponsor
University of Chicago
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer